PB2219: POLYPHARMACY AND DRUG-TO-DRUG INTERACTIONS MAY HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS

• Ivan Krecak,
• Ljerka Pivac,
• Eva Cubric,
• Marko Lucijanic,
• Marko Skelin

Affiliations

Ivan Krecak

1 General Hospital of Sibenik-Knin County, Department of Internal medicine, Sibenik, Croatia

Ljerka Pivac

2 University Hospital Center Split, Pharmacy Department, Split, Croatia

Eva Cubric

1 General Hospital of Sibenik-Knin County, Department of Internal medicine, Sibenik, Croatia

Marko Lucijanic

3 University Hospital Dubrava, Division of Hematology, Zagreb, Croatia

Marko Skelin

4 General Hospital of Sibenik-Knin County, Pharmacy Department, Sibenik, Croatia